Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease beta 1- but not

D J Heal1, S A Butler, E M Hurst

  • 1Research Department, Boots Company PLC, Nottingham, England.

Journal of Neurochemistry
|October 1, 1989
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nalfurafine is Aversive at Antinociceptive Doses in Mice.

Pharmacology research & perspectives·2025
Same author

Electrophysiological analysis of paraventricular thalamic neurons co-expressing kappa and mu opioid receptors.

Neuropharmacology·2025
Same author

Psychedelics: Threshold of a Therapeutic Revolution.

Neuropharmacology·2023
Same author

Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.

Neuropharmacology·2022
Same author

Preclinical Assessment of the Abuse Potential of Purified Botanical Cannabidiol: Self-Administration, Drug Discrimination, and Physical Dependence.

The Journal of pharmacology and experimental therapeutics·2022
Same author

Using a model based fourth-corner analysis to explain vegetation change following an extraordinary fire disturbance.

Oecologia·2016

Antidepressants and electroconvulsive shocks down-regulate beta-1 adrenoceptors in rat cortex. Clenbuterol, however, reduces beta-2 adrenoceptors, indicating subtype-specific drug effects on beta-adrenoceptor populations.

Area of Science:

  • Neuropharmacology
  • Adrenergic Receptor Research

Background:

  • Beta-adrenoceptors (β-ARs) are crucial for various central nervous system functions.
  • Understanding how different drug classes affect β-AR subtypes is vital for therapeutic development.

Purpose of the Study:

  • To investigate the effects of chronic and short-term administration of monoamine reuptake inhibitors, monoamine oxidase inhibitors, electroconvulsive shocks (ECSs), and clenbuterol on beta-1 and beta-2 adrenoceptor populations in the rat cortex.

Main Methods:

  • Quantitative receptor autoradiography using [3H]dihydroalprenolol.
  • Selective displacement with CGP 20712A to quantify beta-1 adrenoceptors.
  • Calculation of beta-2 adrenoceptor density by difference.
  • Administration of drugs (sibubutramine HCl, amitriptyline, desipramine, zimeldine, tranylcypromine, clenbuterol) and ECS over 3 or 10 days.

Related Experiment Videos

Main Results:

  • Chronic treatment with sibutramine HCl, amitriptyline, desipramine, zimeldine, tranylcypromine, and ECS significantly reduced total cortical beta-adrenoceptors, primarily by down-regulating beta-1 adrenoceptors.
  • Clenbuterol treatment selectively reduced beta-2 adrenoceptor density.
  • Short-term (3-day) administration of sibutramine HCl and desipramine also led to a reduction in beta-1 adrenoceptors.

Conclusions:

  • Monoamine reuptake inhibitors, monoamine oxidase inhibitors, and ECS predominantly down-regulate beta-1 adrenoceptors in the rat cortex.
  • Beta-2 adrenoceptors are selectively affected by clenbuterol.
  • These findings highlight the subtype-specific regulation of beta-adrenoceptors by different classes of psychoactive drugs.